NEUROBO PHARMACEUTICALS INC's ticker is and the CUSIP is 64132R206. A total of 14 filers reported holding NEUROBO PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,795 | – | 22,678 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtu Financial LLC | 32,270 | $15 | 0.00% |
| UBS Group AG | 142 | $68 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 8 | $4 | 0.00% |
| WELLS FARGO & COMPANY/MN | 188 | $89 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 138,672 | $66,033 | 0.00% |
| STATE STREET CORP | 22,678 | $10,795 | 0.00% |
| MORGAN STANLEY | 2 | $1 | 0.00% |
| COMERICA BANK | 22 | $10 | 0.00% |
| BlackRock Inc. | 42,199 | $20,087 | 0.00% |